Search Results - "Esparragosa Vázquez, Inés"
-
1
Autoimmune glial fibrillary acidic protein astrocytopathy: case report of a treatable cause of rapidly progressive dementia
Published in Journal of neurology (01-06-2021)Get full text
Journal Article -
2
RNU6-1 in circulating exosomes differentiates GBM from non-neoplastic brain lesions and PCNSL but not from brain metastases
Published in Neuro-oncology advances (01-01-2020)“…Abstract Background Glioblastoma (GBM) is the most common malignant primary brain tumor in adults. Circulating biomarkers may assist in the processes of…”
Get full text
Journal Article -
3
T2‐Fluid‐attenuated inversion recovery (FLAIR) pseudoprogression in patients with anaplastic oligodendrogliomas treated with procarbazine, lomustine and vincristine (PCV) chemotherapy alone
Published in European journal of neurology (01-09-2023)“…Background Pseudoprogression in gliomas has been extensively described after radiotherapy with or without chemotherapy, but not after chemotherapy alone. Here…”
Get full text
Journal Article -
4
The Role of Radiotherapy, Chemotherapy, and Targeted Therapies in Adult Intramedullary Spinal Cord Tumors
Published in Cancers (06-08-2024)“…Intramedullary primary spinal cord tumors are rare in adults and their classification has recently evolved. Their treatment most frequently relies on maximal…”
Get full text
Journal Article -
5
Olaparib in recurrent isocitrate dehydrogenase mutant high-grade glioma: A phase 2 multicenter study of the POLA Network
Published in Neuro-oncology advances (01-01-2024)“…Abstract Background Based on preclinical studies showing that IDH-mutant (IDHm) gliomas could be vulnerable to PARP inhibition we launched a multicenter phase…”
Get full text
Journal Article -
6
-
7
Oncolytic DNX-2401 Virus for Pediatric Diffuse Intrinsic Pontine Glioma
Published in The New England journal of medicine (30-06-2022)“…A total of 12 pediatric patients with diffuse intrinsic pontine glioma were treated with a direct infusion of an oncolytic virus, followed by radiotherapy. The…”
Get full text
Journal Article -
8
Nivolumab and Ipilimumab-induced myositis and myocarditis mimicking a myasthenia gravis presentation
Published in Neuromuscular disorders : NMD (01-01-2020)“…•Differentiating among the neuromuscular immune-related disorders is a challenge.•Cessation of ICIs and immunomodulators are crucial in the management of…”
Get full text
Journal Article -
9
A Phase II Study to Evaluate the Safety and Efficacy of Prasinezumab in Early Parkinson's Disease (PASADENA): Rationale, Design, and Baseline Data
Published in Frontiers in neurology (01-10-2021)“…Currently available treatments for Parkinson's disease (PD) do not slow clinical progression nor target alpha-synuclein, a key protein associated with the…”
Get full text
Journal Article -
10
Olaparib in recurrent IDH mutant high-grade glioma: a phase 2 multicenter study of the POLA Network
Published in Neuro-oncology advances (27-05-2024)Get full text
Journal Article -
11
Hoehn and Yahr Stage and Striatal Dat-SPECT Uptake Are Predictors of Parkinson's Disease Motor Progression
Published in Frontiers in neuroscience (13-12-2021)“…Currently, no treatments available for Parkinson's disease (PD) can slow PD progression. At the early stage of the disease, only a subset of individuals with…”
Get full text
Journal Article -
12
Pseudoprogression en Flair chez les patients atteints d’oligodendrogliomes anaplasiques traités par chimiothérapie seule
Published in Revue neurologique (01-04-2023)“…Le phénomène de pseudoprogression a été bien décrit chez les patients atteints de gliomes traités par radiothérapie avec ou sans chimiothérapie, mais pas après…”
Get full text
Journal Article